Company news
TRON Group Inc. news in 2025
TRON Group Inc.'s news releases, calls and decks from 2025, newest first.
Alchem Announces Poster Presentation on its AD=229 Program at Society for Neuroscience 2025 Conference
December 2, 2025
Dr. Aman Chauhan Presents Phase 1 Study on Neuroendocrine Tumors at ESMO 2025
October 19, 2025
ESMO Abstract “1709MO - Multi-center NCI-sponsored phase I study of triapine in combination with 177Lu-dotatate in patients with well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NETs)”
October 12, 2025
Nanopharmaceutics Announces Presentation of National Cancer Institute sponsored Phase I Study with Triapine at ESMO 2025
September 9, 2025
Nanopharmaceutics Announces End of Patient Recruitment for NCI Phase II Study with Triapine for Neuroendocrine Tumors
July 17, 2025
Nanopharmaceutics Inc. Announces Initiation of Clinical Study of Triapine + Radiation for Glioblastoma or Astrocytoma
March 31, 2025
TRON Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
March 31, 2025